Lantern CEO John Zutter, left, and the company's new chief medical officer, Dr. Jason Tibbels. [Image sources: Lantern, courtesy photos, DI studio]
The Dallas-based specialty care platform, valued at $1 billion in 2023 and now rebranded as Lantern, has expanded its clinical team and advisory board with leaders bringing experience at Hinge Health and CVS Health. Lantern also unveiled a new division, Lantern Infusion Care, in its "promise to ensure top-tier specialty care isn't reserved for the lucky few."
The moves follow a $92 million investment from Insight Partners in December.